The Penlon ESO 2 Emergency Ventilator today received internationally recognised CE Mark approval for the treatment of COVID-19 patients
Penlon today announced that the Company received CE Mark approval for its ESO 2 Emergency Ventilator for the treatment of COVID-19 patients. For the past three months, Penlon has been working as part of the ‘VentilatorChallengeUK’ consortium to mass-produce thousands of ESO 2 Emergency Ventilators for the NHS in the fight against COVID-19. During that period working was going on to ensure that the ESO 2 would be available outside the UK.
Using its ventilation expertise, Penlon rapidly developed the ESO 2 Emergency Ventilator, based on the existing AV-S anaesthesia ventilator platform. The purpose of the ESO 2 is to save lives by ventilating the sickest patients until they are strong enough to be transferred to one of the limited number of ICU ventilators available for recovery.
With international CE certification, the ESO 2 Emergency Ventilator will soon be available through Penlon’s global distribution network.
Mary Ryan, Penlon’s Director Quality Assurance and Regulatory Affairs said:
03/06/2026
Penlon will be exhibiting a range of anaesthetic machines, patient monitors, and accessories at Euroanaesthesia 2026 this month.
02/06/2026
Penlon will return to Coventry to exhibit our anaesthetic machines, patient monitors, infusion pumps and accessories at the EBME Expo 2026. The EBME Expo is the UK’s largest gathering of EBME Managers, Clinical Engineers and Supporting Healthcare Professionals.
05/11/2020
Penlon will remain open for business during the new restrictions due to start on Thursday, 5 November in England.
17/08/2020
Ventilator Challenge UK Consortium presented with a President’s Special Award from the Royal Academy of Engineering for their part in tackling COVID-19.